Referral
For anyone who comes across the occasional company: angels, operators, lawyers and assignees. One intro, no commitment.
Partner program
Refer a company. Share in what it recovers.
Investors, accelerators, university tech transfer offices and advisors know which companies are sitting on valuable data, often before the companies do. Point them our way, and we'll build your referral economics into the deal.
P
Under offer
Portfolio company
Protein engineering, winding down
IntroducedYou make a warm intro
AssessedData inventory and rights check
Under offerCompany reviews structure
ClosedSale or license signed
Paid outReferral terms settled at close
Three ways in.
Portfolio
For funds, studios, accelerators and super angels. We review data assets across your portfolio and add a data step to your wind-down playbook.
Institutional
For universities, tech transfer offices and research institutes with lab and core-facility data to license on a standing basis.
Built for people who see companies first.
The best time to save a company's data is before the cloud account lapses and the team scatters. Partners make that possible.
Co-branded shutdown playbook
A data-preservation checklist you can send to any portfolio company that's running low on runway.
Portfolio data audit
A confidential view of which companies hold valuable data, before anyone needs to sell.
Referral dashboard
Track every intro from first call to payout, without chasing anyone for an update.
Economics in the deal
Referral terms are written into each sale or license, including follow-on licensing where it fits.
Economics built into every deal.
There's no rate card. Referral terms are set for each deal and written into the sale or license itself, so everyone can see them. They can be paid to you, to the company or to its creditors, whichever suits how you work.
Partner questions.
Does it cost anything to join?
No. You're only paid when a deal closes, and you never pay us.
Can an investor take a fee on its own portfolio company?
Yes, with disclosure to the company. Many funds prefer to have the fee paid to the company or its creditors instead, and we can do that too.
Is the company obliged to sell?
No. An assessment is free and confidential, and the company decides whether to proceed.
Which companies are a good fit?
Any deep tech, biotech or hard tech company that has generated its own experimental, test or instrument data, whether it's operating, winding down or already closed.
Become a partner.
Tell us who you are. We'll send the partner agreement and your co-branded playbook.